Carregant...
Disease modifying potential of glatiramer acetate in Huntington's disease
BACKGROUND: Deficiencies in brain-derived-neurotrophic-factor have been implicated in the pathogenesis of Huntington's disease (HD). OBJECTIVE: Glatiramer acetate, an FDA- approved drug used for the treatment of multiple sclerosis, has been shown to increase brain-derived-neurotrophic-factor le...
Guardat en:
| Publicat a: | J Huntingtons Dis |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4480978/ https://ncbi.nlm.nih.gov/pubmed/25300334 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JHD-140110 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|